Bull in Advantage hereby designates the following companies as part of our Hot Stock Watchlist today. For more top picks every day, be sure to subscribe to our daily reports. Copies of these reports may be found on our blog at: http://bluehorseshoestocks.com.
Advanced Cell Technology, Inc. (OTCQB: ACTC)
Advanced Cell Technology ("ACT"; ACTC), is a biotechnology company developing cellular therapies for treating diseases that impact millions of people worldwide.
Helmed by Chairman and CEO Gary Rabin, ACT is currently conducting the only human embryonic stem cell (hESC)-based clinical trials: two Phase I/II trials in the US and one in Europe. Initial results from the two US trials were published earlier this year in The Lancet.
ACT is also focused on its Hemangioblast platform for treating blood and cardiovascular diseases, and its mesenchymal stem cell program. ACT?s patented "embryo-safe" technique for deriving hESCs without harming embryos was documented in Nature.
Kenergy Scientific Inc. (OTCQB: KNSC)
Kenergy Scientific Inc currently has significant long term plans to engage in future research and development, to create valuable intellectual property rights and/or to launch new products. The Company will acquire third party patent rights, develop its own patent rights and evolve both new product and intellectual property transfer (sale or license) opportunities..
iMing Corp. (PINKSHEETS: IMNG)
IMING Corp is a provider of high-definition web based television and video?s for the Chinese Market with the goal of being a leading provider of set-top boxes in Asia and expanding into North America and Europe.
Sentry Technology Corp. (PINKSHEETS: SKVY)
Sentry Technology Corporation designs, manufactures, sells and installs Closed Circuit Television (CCTV) solutions, Electro-Magnetic (EM) and RFID based Library security and self-service systems. Our CCTV product line features SentryVisiona, SmartTrack(TM), a proprietary, patented traveling Surveillance System.
Nile Therapeutics, Inc. (PINKSHEETS: NLTX)
Nile Therapeutics, Inc. is a clinical stage biopharmaceutical company developing innovative products for the treatment of cardiovascular disease, with an initial focus on heart failure.
About Bull in Advantage:
For over 10 years, the Bull in Advantage Network has been working tirelessly to provide the public with the #1 stock newsletter available.
We scan thousands of stocks daily to find the very best 52-week low bounce-plays, high-volume momentum movers, and promising start-ups with unique business models. We also cover big board and blue-chip stocks along with related options trading ideas. We gather information on all of the best opportunities, and pass it along to you.
What sets us apart from so many competitors is our coverage of multiple symbols each day. We strive to provide a diverse array of stocks with real potential, and present them in a very straightforward manner. Sign up for our free newsletter today, and welcome to the Bull in Advantage family!
The assembled information disseminated by Bull in Advantage is for informative purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bull in Advantage LLC owners/operators are not licensed financial advisors or analysts in any jurisdiction whatsoever. Always do your own due diligence, and consult a financial advisor before making any investment. Full compensatory disclosure is available at http://bullinadvantage.com/disclaimer
Bull in Advantage LLC
Phone: (561) 228-1692
SOURCE Bull in Advantage, LLC
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here